The latest closing stock price for Bellevue Life Sciences Acquisition as of February 04, 2025 is 11.28.
An investor who bought $1,000 worth of Bellevue Life Sciences Acquisition stock at the IPO in 2023 would have $117 today, roughly 0 times their original investment - a 5.68% compound annual growth rate over 2 years.
The all-time high Bellevue Life Sciences Acquisition stock closing price was 12.25 on November 14, 2024.
The Bellevue Life Sciences Acquisition 52-week high stock price is 13.40, which is 18.8% above the current share price.
The Bellevue Life Sciences Acquisition 52-week low stock price is 10.56, which is 6.4% below the current share price.
The average Bellevue Life Sciences Acquisition stock price for the last 52 weeks is 10.92.
An investor who bought $1,000 worth of Bellevue Life Sciences Acquisition stock at the IPO in 2023 would have $117 today, roughly 0 times their original investment - a 5.68% compound annual growth rate over 2 years.
The all-time high Bellevue Life Sciences Acquisition stock closing price was 12.25 on November 14, 2024.
The Bellevue Life Sciences Acquisition 52-week high stock price is 13.40, which is 18.8% above the current share price.
The Bellevue Life Sciences Acquisition 52-week low stock price is 10.56, which is 6.4% below the current share price.
The average Bellevue Life Sciences Acquisition stock price for the last 52 weeks is 10.92.